Stock CRBP CORBUS PHARMACEUTICALS HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Corbus Pharmaceuticals Holdings, Inc.

Equities

CRBP

US21833P3010

Market Closed - Nasdaq
Other stock markets
 21:00:00 10/05/2024 BST 		5-day change 1st Jan Change
42.99 USD -1.71% Intraday chart for Corbus Pharmaceuticals Holdings, Inc. +10.88% +611.75%
05-08 Oppenheimer Adjusts Corbus Pharmaceuticals Price Target to $60 From $58, Maintains Outperform Rating MT
05-07 Corbus Pharmaceuticals Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Evolution of the average Target Price on Corbus Pharmaceuticals Holdings, Inc.

Price target over the last 5 years

History of analyst recommendation changes

9785139.JvTmaLUBDj2fAjHz3xMecuJGI-TXSvwpjOBwc_m1XRk.YY2hOph5eA7WQWLC7ndJJYEQbqK_Z5d2-aQlGMCNLX5hprwuxFRhZ_VOYA~94d3b9098dc06fe1873e705339a10c7a

Analyst Recommendations on Corbus Pharmaceuticals Holdings, Inc.

Oppenheimer Adjusts Corbus Pharmaceuticals Price Target to $60 From $58, Maintains Outperform Rating MT
Oppenheimer Adjusts Corbus Pharmaceuticals Price Target to $58 From $51, Maintains Outperform Rating MT
Jefferies Upgrades Corbus Pharmaceuticals Holdings to Buy From Hold MT
Oppenheimer Adjusts Corbus Pharmaceuticals Price Target to $51 From $20, Maintains Outperform Rating MT
Oppenheimer Adjusts Corbus Pharmaceuticals Price Target to $20 From $22, Maintains Outperform Rating MT
Oppenheimer Upgrades Corbus Pharmaceuticals to Outperform From Perform, $22 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
42.99 USD
Average target price
68 USD
Spread / Average Target
+58.18%
High Price Target
76 USD
Spread / Highest target
+76.79%
Low Price Target
60 USD
Spread / Lowest Target
+39.57%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Corbus Pharmaceuticals Holdings, Inc.

Oppenheimer
Jefferies & Co.

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. CRBP Stock
  4. Consensus Corbus Pharmaceuticals Holdings, Inc.